Related Experiment Video
Updated: Jun 12, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Diagnosis of Pleural Mesothelioma: Is Everything Solved at the Present Time?
Elisa Roca1, Avinash Aujayeb2, Philippe Astoul3,4
1Thoracic Oncology, Lung Unit, P. Pederzoli Hospital, Peschiera Del Garda, VR, Italy.
Abstract:
Ranked high in worldwide growing health issues, pleural diseases affect approximately one million people globally per year and are often correlated with a poor prognosis. Among these pleural diseases, malignant pleural mesothelioma (PM), a neoplastic disease mainly due to asbestos exposure, still remains a diagnostic challenge. Timely diagnosis is imperative to define the most suitable therapeutic approach for the patient, but the choice of diagnostic modalities depends on operator experience and local facilities while bearing in mind the yield of each diagnostic procedure. Since the analysis of pleural fluid cytology is not sufficient in differentiating historical features in PM, histopathological and morphological features obtained via tissue biopsies are fundamental. The quality of biopsy samples is crucial and often requires highly qualified expertise. Since adequate tissue biopsy is essential, medical or video-assisted thoracoscopy (MT or VATS) is proposed as the most suitable approach, with the former being a physician-led procedure. Indeed, MT is the diagnostic gold standard for malignant pleural pathologies. Moreover, this medical or surgical approach can allow diagnostic and therapeutic procedures: it provides the possibility of video-assisted biopsies, the drainage of high volumes of pleural fluid and the administration of sterile calibrated talcum powder under visual control in order to achieve pleurodesis, placement of indwelling pleural catheters if required and in a near future potential intrapleural therapy. In this context, dedicated diagnostic pathways remain a crucial need, especially to quickly and properly diagnose PM. Lastly, the interdisciplinary approach and multidisciplinary collaboration should always be implemented in order to direct the patient to the best customised diagnostic and therapeutic pathway. At the present time, the diagnosis of PM remains an unsolved problem despite MDT (multidisciplinary team) meetings, mainly because of the lack of standardised diagnostic work-up. This review aims to provide an overview of diagnostic procedures in order to propose a clear strategy.
Insights
Malignant pleural mesothelioma (PM) diagnosis is challenging, often requiring tissue biopsies via medical thoracoscopy (MT) or video-assisted thoracoscopy (VATS). Standardized diagnostic pathways are needed for timely and accurate PM detection.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Pleural diseases affect millions annually, with malignant pleural mesothelioma (PM) posing a significant diagnostic challenge.
- PM, often linked to asbestos exposure, has a poor prognosis, necessitating early and accurate diagnosis for effective treatment.
- Current diagnostic methods, including pleural fluid cytology, are often insufficient for definitive PM diagnosis.
Purpose of the Study:
- To review current diagnostic procedures for malignant pleural mesothelioma (PM).
- To highlight the importance of histopathological analysis from tissue biopsies.
- To propose a clear diagnostic strategy for PM, emphasizing standardized work-up.
Main Methods:
- Review of diagnostic modalities for pleural diseases, focusing on malignant pathologies.
- Emphasis on tissue biopsy techniques, including medical thoracoscopy (MT) and video-assisted thoracoscopy (VATS).
- Discussion of the role of MT as the diagnostic gold standard for malignant pleural conditions.
Main Results:
- Pleural fluid cytology alone is insufficient for differentiating PM features.
- Tissue biopsies obtained via MT or VATS are crucial for accurate histopathological diagnosis.
- MT is considered the gold standard, offering both diagnostic and therapeutic capabilities.
Conclusions:
- Standardized diagnostic pathways are essential for timely and accurate PM diagnosis.
- An interdisciplinary and multidisciplinary approach is vital for optimal patient management.
- Despite multidisciplinary team (MDT) meetings, PM diagnosis remains a challenge due to the lack of standardized diagnostic work-up.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax-II
Clinical Manifestations:
Pleura of the Lungs
Pericarditis II: Clinical features and Diagnostic Tests
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

